| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.669 | 0.005 | 0.71 | DNA damaging | 0.541 0.011 DBMET01421 0.66 0.006 DBMET01422 0.71 0.005 DBMET01423 0.44 0.021 DBMET01424 | DBMET01423 | |
| 0.643 | 0.003 | 0.739 | Alkylator | 0.506 0.005 DBMET01421 0.517 0.005 DBMET01422 0.739 0.002 DBMET01423 0.521 0.004 DBMET01424 | DBMET01423 | |
| 0.356 | 0.029 | 0.376 | DNA synthesis inhibitor | 0.354 0.029 DBMET01421 0.376 0.025 DBMET01422 0.359 0.028 DBMET01423 0.237 0.076 DBMET01424 | DBMET01422 | |
| 0.38 | 0.072 | 0.407 | Immunosuppressant | 0.407 0.06 DBMET01421 0.372 0.075 DBMET01422 0.379 0.072 DBMET01423 0.264 0.138 DBMET01424 | DBMET01421 | |
| 0.298 | 0.042 | 0.361 | Cyclic AMP phosphodiesterase inhibitor | 0.237 0.07 DBMET01421 0.335 0.03 DBMET01422 0.361 0.023 DBMET01423 0.317 0.035 DBMET01424 | DBMET01423 | |
| 0.275 | 0.037 | 0.336 | Growth hormone agonist | 0.219 0.052 DBMET01422 0.244 0.045 DBMET01423 0.336 0.025 DBMET01424 | DBMET01424 | |
| 0.3 | 0.082 | 0.398 | Immunomodulator | 0.22 0.142 DBMET01422 0.328 0.068 DBMET01423 0.398 0.044 DBMET01424 | DBMET01424 | |
| 0.35 | 0.138 | 0.368 | Apoptosis agonist | 0.298 0.174 DBMET01421 0.368 0.129 DBMET01422 0.326 0.155 DBMET01423 | DBMET01422 | |
| 0.247 | 0.052 | 0.377 | Anesthetic general | 0.191 0.08 DBMET01421 0.211 0.069 DBMET01422 0.368 0.021 DBMET01423 0.377 0.019 DBMET01424 | DBMET01424 | |
| 0.19 | 0.01 | 0.232 | Antimetabolite | 0.081 0.019 DBMET01421 0.232 0.008 DBMET01422 0.19 0.01 DBMET01423 0.125 0.013 DBMET01424 | DBMET01422 | |
| 0.269 | 0.089 | 0.338 | Immunostimulant | 0.175 0.136 DBMET01421 0.319 0.073 DBMET01422 0.313 0.075 DBMET01423 0.338 0.068 DBMET01424 | DBMET01424 | |
| 0.251 | 0.079 | 0.312 | Gastrin inhibitor | 0.257 0.071 DBMET01422 0.193 0.159 DBMET01423 0.312 0.025 DBMET01424 | DBMET01424 | |
| 0.166 | 0.013 | 0.171 | Thioredoxin inhibitor | 0.142 0.02 DBMET01421 0.171 0.012 DBMET01422 0.138 0.021 DBMET01423 0.084 0.074 DBMET01424 | DBMET01422 | |
| 0.157 | 0.016 | 0.202 | Phosphodiesterase I inhibitor | 0.202 0.01 DBMET01422 0.12 0.027 DBMET01423 0.091 0.057 DBMET01424 | DBMET01422 | |
| 0.259 | 0.119 | 0.435 | Antithrombotic | 0.197 0.181 DBMET01421 0.197 0.18 DBMET01422 0.311 0.081 DBMET01423 0.435 0.041 DBMET01424 | DBMET01424 | |
| 0.173 | 0.034 | 0.173 | DNA intercalator | 0.109 0.065 DBMET01421 0.161 0.038 DBMET01422 0.162 0.038 DBMET01423 0.089 0.086 DBMET01424 | ||
| 0.253 | 0.115 | 0.299 | Interleukin 2 agonist | 0.265 0.103 DBMET01421 0.262 0.106 DBMET01422 0.245 0.125 DBMET01423 0.299 0.074 DBMET01424 | DBMET01424 | |
| 0.254 | 0.124 | 0.365 | Sodium/bile acid cotransporter inhibitor | 0.248 0.13 DBMET01421 0.255 0.123 DBMET01422 0.315 0.066 DBMET01423 0.365 0.031 DBMET01424 | DBMET01424 | |
| 0.253 | 0.123 | 0.417 | Cholesterol antagonist | 0.39 0.052 DBMET01422 0.277 0.106 DBMET01423 0.417 0.046 DBMET01424 | DBMET01424 | |
| 0.184 | 0.067 | 0.219 | Lipocortins synthesis antagonist | 0.169 0.081 DBMET01421 0.173 0.078 DBMET01422 0.167 0.084 DBMET01423 0.219 0.045 DBMET01424 | DBMET01424 | |
| 0.212 | 0.11 | 0.334 | Spasmolytic | 0.334 0.058 DBMET01421 0.173 0.143 DBMET01422 0.298 0.071 DBMET01423 0.202 0.118 DBMET01424 | DBMET01421 | |
| 0.212 | 0.115 | 0.231 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.107 DBMET01422 0.231 0.089 DBMET01424 | DBMET01424 | |
| 0.109 | 0.017 | 0.109 | Ribonucleoside-diphosphate reductase inhibitor | 0.055 0.037 DBMET01421 0.088 0.022 DBMET01422 0.084 0.023 DBMET01423 0.058 0.035 DBMET01424 | ||
| 0.135 | 0.047 | 0.152 | DNA repair enzyme inhibitor | 0.148 0.033 DBMET01421 0.152 0.03 DBMET01422 0.115 0.083 DBMET01423 | DBMET01422 | |
| 0.168 | 0.082 | 0.188 | Succinate dehydrogenase inhibitor | 0.152 0.108 DBMET01421 0.188 0.06 DBMET01422 0.161 0.093 DBMET01423 0.153 0.106 DBMET01424 | DBMET01422 | |
| 0.122 | 0.037 | 0.122 | Prolactin inhibitor | 0.102 0.053 DBMET01422 | ||
| 0.118 | 0.033 | 0.14 | Triose-phosphate isomerase inhibitor | 0.104 0.044 DBMET01421 0.14 0.023 DBMET01422 0.115 0.035 DBMET01423 0.106 0.042 DBMET01424 | DBMET01422 | |
| 0.105 | 0.02 | 0.105 | Ribonucleotide reductase inhibitor | 0.054 0.04 DBMET01421 0.087 0.024 DBMET01422 0.082 0.026 DBMET01423 0.057 0.038 DBMET01424 | ||
| 0.163 | 0.078 | 0.192 | Catenin beta inhibitor | 0.182 0.049 DBMET01422 0.144 0.122 DBMET01423 0.192 0.039 DBMET01424 | DBMET01424 | |
| 0.121 | 0.038 | 0.139 | Folate antagonist | 0.099 0.066 DBMET01421 0.131 0.031 DBMET01422 0.106 0.055 DBMET01423 0.139 0.027 DBMET01424 | DBMET01424 | |
| 0.111 | 0.03 | 0.131 | Bile acid receptor antagonist | 0.097 0.056 DBMET01421 0.096 0.058 DBMET01423 0.131 0.013 DBMET01424 | DBMET01424 | |
| 0.127 | 0.049 | 0.153 | Ferrochelatase inhibitor | 0.153 0.036 DBMET01421 0.136 0.044 DBMET01422 0.135 0.045 DBMET01424 | DBMET01421 | |
| 0.129 | 0.051 | 0.129 | Cystathionine beta-synthase inhibitor | 0.09 0.089 DBMET01422 | ||
| 0.127 | 0.049 | 0.191 | Photosensitizer | 0.112 0.068 DBMET01421 0.149 0.031 DBMET01422 0.105 0.079 DBMET01423 0.191 0.015 DBMET01424 | DBMET01424 | |
| 0.123 | 0.047 | 0.213 | GABA C receptor agonist | 0.213 0.018 DBMET01422 0.141 0.038 DBMET01424 | DBMET01422 | |
| 0.101 | 0.027 | 0.167 | Peroxisome proliferator-activated receptor gamma agonist | 0.109 0.023 DBMET01423 0.167 0.009 DBMET01424 | DBMET01424 | |
| 0.08 | 0.007 | 0.13 | Thymidylate synthase inhibitor | 0.054 0.023 DBMET01421 0.13 0.004 DBMET01422 0.079 0.008 DBMET01423 0.083 0.007 DBMET01424 | DBMET01422 | |
| 0.093 | 0.023 | 0.117 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.024 DBMET01421 0.117 0.016 DBMET01422 0.088 0.025 DBMET01423 0.08 0.028 DBMET01424 | DBMET01422 | |
| 0.074 | 0.006 | 0.08 | Angiotensin AT2 receptor antagonist | 0.031 0.013 DBMET01422 0.065 0.008 DBMET01423 0.08 0.005 DBMET01424 | DBMET01424 | |
| 0.094 | 0.035 | 0.096 | Thioredoxin reductase inhibitor | 0.088 0.044 DBMET01421 0.096 0.032 DBMET01422 0.085 0.049 DBMET01423 | DBMET01422 | |
| 0.092 | 0.036 | 0.227 | Interferon agonist | 0.097 0.031 DBMET01422 0.101 0.028 DBMET01423 0.227 0.005 DBMET01424 | DBMET01424 | |
| 0.088 | 0.044 | 0.088 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET01423 | ||
| 0.084 | 0.041 | 0.101 | Glutamate dehydrogenase inhibitor | 0.076 0.049 DBMET01421 0.101 0.03 DBMET01422 | DBMET01422 | |
| 0.208 | 0.175 | 0.319 | Vasodilator, coronary | 0.268 0.117 DBMET01422 0.277 0.108 DBMET01423 0.319 0.073 DBMET01424 | DBMET01424 | |
| 0.202 | 0.171 | 0.212 | Thioredoxin glutathione reductase inhibitor | 0.191 0.18 DBMET01421 0.212 0.162 DBMET01422 0.205 0.169 DBMET01423 | DBMET01422 | |
| 0.075 | 0.048 | 0.178 | Telomerase inhibitor | 0.178 0.016 DBMET01422 | DBMET01422 | |
| 0.077 | 0.05 | 0.092 | GABA aminotransferase inhibitor | 0.092 0.033 DBMET01422 | DBMET01422 | |
| 0.16 | 0.134 | 0.325 | Platelet antagonist | 0.179 0.118 DBMET01422 0.172 0.124 DBMET01423 0.325 0.045 DBMET01424 | DBMET01424 | |
| 0.03 | 0.006 | 0.033 | Angiotensin AT1A receptor antagonist | 0.023 0.012 DBMET01422 0.027 0.008 DBMET01423 0.033 0.005 DBMET01424 | DBMET01424 | |
| 0.153 | 0.13 | 0.291 | Insulin sensitizer | 0.188 0.086 DBMET01423 0.291 0.018 DBMET01424 | DBMET01424 | |
| 0.113 | 0.092 | 0.159 | NADPH oxidase inhibitor | 0.159 0.049 DBMET01424 | DBMET01424 | |
| 0.064 | 0.045 | 0.128 | Interferon inducer | 0.069 0.036 DBMET01422 0.069 0.036 DBMET01423 0.128 0.006 DBMET01424 | DBMET01424 | |
| 0.049 | 0.031 | 0.078 | Cytokine production stimulant | 0.078 0.005 DBMET01424 | DBMET01424 | |
| 0.167 | 0.151 | 0.302 | Hypoglycemic | 0.183 0.13 DBMET01421 0.213 0.101 DBMET01423 0.302 0.052 DBMET01424 | DBMET01424 | |
| 0.043 | 0.028 | 0.057 | Angiotensin AT1 receptor antagonist | 0.057 0.009 DBMET01424 | DBMET01424 | |
| 0.078 | 0.064 | 0.096 | Glutathione S-transferase inhibitor | 0.096 0.041 DBMET01422 0.082 0.058 DBMET01423 | DBMET01422 | |
| 0.054 | 0.043 | 0.082 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.047 DBMET01421 0.082 0.013 DBMET01422 0.059 0.032 DBMET01423 0.061 0.027 DBMET01424 | DBMET01422 | |
| 0.025 | 0.018 | 0.034 | Prostaglandin H2 antagonist | 0.026 0.017 DBMET01422 0.034 0.01 DBMET01424 | DBMET01424 | |
| 0.117 | 0.112 | 0.146 | Farnesoid X receptor antagonist | 0.146 0.057 DBMET01424 | DBMET01424 | |
| 0.032 | 0.028 | 0.046 | Angiotensin II receptor antagonist | 0.046 0.009 DBMET01424 | DBMET01424 | |
| 0.054 | 0.05 | 0.06 | Androgen agonist | 0.054 0.049 DBMET01421 0.06 0.042 DBMET01422 | DBMET01422 | |
| 0.202 | 0.199 | 0.4 | Histamine release inhibitor | 0.261 0.148 DBMET01422 0.4 0.076 DBMET01424 | DBMET01424 | |
| 0.078 | 0.075 | 0.085 | T cell inhibitor | 0.079 0.072 DBMET01421 0.085 0.048 DBMET01423 | DBMET01423 | |
| 0.041 | 0.039 | 0.054 | Adenosine deaminase inhibitor | 0.045 0.036 DBMET01422 0.041 0.039 DBMET01423 0.054 0.026 DBMET01424 | DBMET01424 | |
| 0.138 | 0.136 | 0.176 | Neurotensin receptor agonist | 0.176 0.055 DBMET01422 | DBMET01422 | |
| 0.085 | 0.085 | 0.242 | Gastric antisecretory | 0.109 0.054 DBMET01422 0.099 0.067 DBMET01423 0.242 0.007 DBMET01424 | DBMET01424 | |
| 0.033 | 0.038 | 0.047 | Retinoid X receptor antagonist | 0.047 0.015 DBMET01424 | DBMET01424 | |
| 0.035 | 0.04 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.039 0.029 DBMET01421 | DBMET01421 | |
| 0.061 | 0.067 | 0.075 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET01422 0.065 0.061 DBMET01423 0.066 0.06 DBMET01424 | DBMET01422 | |
| 0.009 | 0.017 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.01 DBMET01424 | DBMET01424 | |
| 0.089 | 0.098 | 0.105 | Topoisomerase II inhibitor | 0.105 0.082 DBMET01422 | DBMET01422 | |
| 0.028 | 0.041 | 0.039 | Retinoid X alpha receptor antagonist | 0.039 0.016 DBMET01424 | DBMET01424 | |
| 0.103 | 0.116 | 0.22 | Toll-Like receptor antagonist | 0.113 0.095 DBMET01423 0.22 0.024 DBMET01424 | DBMET01424 | |
| 0.146 | 0.16 | 0.234 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.234 0.05 DBMET01424 | DBMET01424 | |
| 0.016 | 0.032 | 0.031 | Toll-Like receptor 8 agonist | 0.031 0.005 DBMET01424 | DBMET01424 | |
| 0.072 | 0.092 | 0.116 | HIV-1 integrase (Overall Integration) inhibitor | 0.116 0.042 DBMET01422 0.105 0.05 DBMET01424 | DBMET01422 | |
| 0.045 | 0.068 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.04 DBMET01422 0.059 0.026 DBMET01424 | DBMET01424 | |
| 0.02 | 0.044 | 0.039 | Prostaglandin D2 agonist | 0.039 0.013 DBMET01421 | DBMET01421 | |
| 0.108 | 0.132 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.134 0.067 DBMET01422 0.156 0.034 DBMET01424 | DBMET01424 | |
| 0.065 | 0.091 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 DBMET01422 0.075 0.057 DBMET01424 | DBMET01422 | |
| 0.03 | 0.057 | 0.045 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET01422 | DBMET01422 | |
| 0.023 | 0.052 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DBMET01422 | DBMET01422 | |
| 0.075 | 0.106 | 0.111 | Interleukin 1 beta converting enzyme inhibitor | 0.111 0.044 DBMET01424 | DBMET01424 | |
| 0.047 | 0.079 | 0.071 | Prostaglandin F2 alpha antagonist | 0.071 0.031 DBMET01424 | DBMET01424 | |
| 0.032 | 0.064 | 0.041 | AICAR transformylase inhibitor | 0.041 0.036 DBMET01422 | DBMET01422 | |
| 0.05 | 0.084 | 0.076 | Porphobilinogen synthase inhibitor | 0.076 0.05 DBMET01422 0.068 0.058 DBMET01424 | DBMET01422 | |
| 0.169 | 0.203 | 0.281 | Transcription factor NF kappa B inhibitor | 0.281 0.106 DBMET01422 | DBMET01422 | |
| 0.063 | 0.097 | 0.08 | GABA B receptor agonist | 0.08 0.041 DBMET01422 0.079 0.043 DBMET01424 | DBMET01422 | |
| 0.066 | 0.1 | 0.089 | Aminopeptidase B inhibitor | 0.089 0.073 DBMET01422 | DBMET01422 | |
| 0.068 | 0.104 | 0.094 | Alcohol dehydrogenase inhibitor | 0.094 0.06 DBMET01422 | DBMET01422 | |
| 0.07 | 0.114 | 0.094 | Hematopoietic | 0.088 0.054 DBMET01422 0.094 0.042 DBMET01424 | DBMET01424 | |
| 0.074 | 0.12 | 0.092 | Chelator | 0.092 0.09 DBMET01422 | DBMET01422 | |
| 0.069 | 0.116 | 0.092 | Estrogen-related receptor beta agonist | 0.092 0.037 DBMET01424 | DBMET01424 | |
| 0.036 | 0.086 | 0.053 | Biliverdin reductase inhibitor | 0.053 0.049 DBMET01424 | DBMET01424 | |
| 0.057 | 0.108 | 0.181 | NMDA receptor antagonist | 0.181 0.017 DBMET01422 | DBMET01422 | |
| 0.077 | 0.128 | 0.1 | Adenylate kinase inhibitor | 0.09 0.088 DBMET01422 0.1 0.067 DBMET01424 | DBMET01424 | |
| 0.121 | 0.174 | 0.293 | Platelet aggregation inhibitor | 0.293 0.038 DBMET01424 | DBMET01424 | |
| 0.1 | 0.154 | 0.14 | Insulin secretagoues | 0.14 0.085 DBMET01424 | DBMET01424 | |
| 0.043 | 0.096 | 0.099 | Prostaglandin-E synthase inhibitor | 0.099 0.027 DBMET01422 | DBMET01422 | |
| 0.064 | 0.122 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET01424 | DBMET01424 | |
| 0.027 | 0.085 | 0.052 | Thromboxane antagonist | 0.052 0.039 DBMET01424 | DBMET01424 | |
| 0.038 | 0.097 | 0.132 | Sphingosine 1-phosphate receptor 4 agonist | 0.132 0.013 DBMET01424 | DBMET01424 | |
| 0.07 | 0.141 | 0.124 | Interleukin 12 antagonist | 0.087 0.08 DBMET01423 0.124 0.026 DBMET01424 | DBMET01424 | |
| 0.009 | 0.083 | 0.023 | Corticotropin releasing factor 1 receptor antagonist | 0.023 0.015 DBMET01424 | DBMET01424 | |
| 0.02 | 0.094 | 0.04 | Erythropoietin receptor agonist | 0.04 0.029 DBMET01424 | DBMET01424 | |
| 0.041 | 0.116 | 0.067 | Glutamate decarboxylase inhibitor | 0.067 0.059 DBMET01424 | DBMET01424 | |
| 0.03 | 0.104 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 DBMET01424 | DBMET01424 | |
| 0.073 | 0.148 | 0.121 | Bone formation stimulant | 0.121 0.084 DBMET01422 | DBMET01422 | |
| 0.033 | 0.109 | 0.076 | Phosphofructokinase-1 inhibitor | 0.076 0.043 DBMET01424 | DBMET01424 | |
| 0.024 | 0.106 | 0.054 | Prostaglandin EP2 antagonist | 0.054 0.048 DBMET01421 | DBMET01421 | |
| 0.064 | 0.149 | 0.121 | DNA polymerase I inhibitor | 0.121 0.068 DBMET01424 | DBMET01424 | |
| 0.085 | 0.171 | 0.134 | Anticoagulant | 0.134 0.096 DBMET01424 | DBMET01424 | |
| 0.041 | 0.126 | 0.057 | Phosphodiesterase 1A inhibitor | 0.057 0.048 DBMET01424 | DBMET01424 | |
| 0.017 | 0.103 | 0.057 | Dihydropteroate synthase inhibitor | 0.057 0.013 DBMET01422 | DBMET01422 | |
| 0.023 | 0.117 | 0.04 | Adenosine uptake inhibitor | 0.04 0.012 DBMET01424 | DBMET01424 | |
| 0.039 | 0.134 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | 0.06 0.047 DBMET01424 | DBMET01424 | |
| 0.03 | 0.13 | 0.057 | Leukotriene antagonist | 0.057 0.055 DBMET01424 | DBMET01424 | |
| 0.054 | 0.156 | 0.076 | Caspase 7 inhibitor | 0.076 0.07 DBMET01424 | DBMET01424 | |
| 0.073 | 0.19 | 0.119 | Histone deacetylase SIRT1 inhibitor | 0.119 0.093 DBMET01424 | DBMET01424 | |
| 0.148 | 0.279 | 0.235 | Apoptosis antagonist | 0.235 0.142 DBMET01424 | DBMET01424 | |
| 0.053 | 0.188 | 0.136 | Phosphodiesterase 7B inhibitor | 0.098 0.059 DBMET01423 0.136 0.027 DBMET01424 | DBMET01424 | |
| 0.062 | 0.199 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.061 DBMET01424 | DBMET01424 | |
| 0.028 | 0.171 | 0.051 | Epithelial sodium channel blocker | 0.051 0.047 DBMET01424 | DBMET01424 | |
| 0.017 | 0.17 | 0.091 | NMDA 2 receptor antagonist | 0.091 0.037 DBMET01422 | DBMET01422 | |
| 0.073 | 0.228 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.081 DBMET01422 | DBMET01422 | |
| 0.135 | 0.29 | 0.215 | Insulysin inhibitor | 0.215 0.136 DBMET01422 | DBMET01422 | |
| 0.017 | 0.189 | 0.029 | Thiazolidinedione | 0.029 0.023 DBMET01424 | DBMET01424 | |
| 0.057 | 0.253 | 0.135 | Angiogenesis stimulant | 0.135 0.132 DBMET01424 | DBMET01424 | |
| 0.074 | 0.275 | 0.173 | Aldehyde oxidase inhibitor | 0.173 0.121 DBMET01424 | DBMET01424 | |
| 0.113 | 0.317 | 0.435 | Vasodilator, peripheral | 0.435 0.045 DBMET01424 | DBMET01424 | |
| 0.075 | 0.282 | 0.127 | Adenylate cyclase stimulant | 0.127 0.109 DBMET01424 | DBMET01424 | |
| 0.06 | 0.272 | 0.124 | Diuretic | 0.124 0.101 DBMET01424 | DBMET01424 | |
| 0.084 | 0.296 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET01424 | DBMET01424 | |
| 0.114 | 0.335 | 0.182 | Peptidyltransferase inhibitor | 0.182 0.124 DBMET01421 0.177 0.134 DBMET01424 | DBMET01421 | |
| 0.056 | 0.29 | 0.12 | Phospholipase A2 inhibitor | 0.12 0.116 DBMET01424 | DBMET01424 | |
| 0.065 | 0.305 | 0.222 | Platelet adhesion inhibitor | 0.133 0.127 DBMET01421 0.136 0.124 DBMET01423 0.222 0.06 DBMET01424 | DBMET01424 | |
| 0.033 | 0.283 | 0.086 | Nitric-oxide synthase inhibitor | 0.086 0.085 DBMET01424 | DBMET01424 | |
| 0.022 | 0.277 | 0.09 | Protein kinase (CK2) alpha inhibitor | 0.09 0.087 DBMET01422 | DBMET01422 | |
| 0.005 | 0.291 | 0.027 | Bombesin 3 receptor agonist | 0.027 0.007 DBMET01422 | DBMET01422 | |
| 0.064 | 0.352 | 0.167 | Vasodilator | 0.167 0.135 DBMET01424 | DBMET01424 | |
| 0.005 | 0.306 | 0.032 | Bombesin agonist | 0.032 0.007 DBMET01422 | DBMET01422 | |
| 0.028 | 0.363 | 0.074 | Phosphodiesterase VI inhibitor | 0.074 0.052 DBMET01424 | DBMET01424 | |
| 0.047 | 0.383 | 0.234 | Antimitotic | 0.234 0.067 DBMET01421 | DBMET01421 | |
| 0.043 | 0.386 | 0.145 | Hypolipemic | 0.145 0.142 DBMET01424 | DBMET01424 | |
| 0.121 | 0.485 | 0.285 | Caspase 9 stimulant | 0.285 0.211 DBMET01424 | DBMET01424 | |
| 0.102 | 0.471 | 0.37 | Cyclophilin D inhibitor | 0.37 0.109 DBMET01424 | DBMET01424 | |
| 0.038 | 0.524 | 0.229 | Cardiotonic | 0.229 0.096 DBMET01424 | DBMET01424 | |
| 0.027 | 0.549 | 0.079 | Interleukin 5 antagonist | 0.079 0.075 DBMET01424 | DBMET01424 | |
| 0.023 | 0.59 | 0.123 | Electron transport complex I inhibitor | 0.123 0.043 DBMET01421 | DBMET01421 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |